New frontiers in lifestyle-related diseases
Author(s)
Bibliographic Information
New frontiers in lifestyle-related diseases
Springer, c2008
Available at 5 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
"The proceedings of the Showa University International Symposium for Life Sciences, 3rd Annual Meeting, held at Showa University on September 13, 2006"--Foreword
Includes bibliographical references and index
Description and Table of Contents
- Volume
-
ISBN 9784431764274
Table of Contents
- 1 Regulation of Feeding and Energy Homeostasis in the Brain(Orphan Neuropeptides and the Regulation of Food Intake;Neuronal Mechanisms of Feeding Regulation by Peptides ほか)
- 2 Lipid Metabolism and Atherosclerosis(Cholesterol Trafficking and Esterification with Relation to Atherosclerosis and Neurodegenerative Diseases;Atherogenic Lipoproteins in Type 2 Diabetes with Nephropathy ほか)
- 3 Risk Factors for Cardiovascular Diseases(Sleep Apnea and Metabolic and Cardiovascular Complications;Sleep Apnea Syndrome and Atherosclerosis ほか)
- 4 Poster Sessions(Onco‐Suppressor p53 Protein Prevents an Alzheimer Disease Mouse Model,Pin1‐Null Mouse from the Increase of Presenilin‐1;Quantification of Mouse Oxidized Low‐Density Lipoprotein by Sandwich ELISA ほか)
by "BOOK database"
Description and Table of Contents
- Volume
-
ISBN 9784431764274
Description
It is my great pleasure to publish New Frontiers in Lifestyle-Related Dis eases, the proceedings of the Showa University International Symposium for Life Sciences, 3rd Annual Meeting, held at Showa University on Sep tember 13, 2006. This symposium was supported, in part, by Grants for the Promotion of the Advancement of Education and Research in Graduate Schools and Ordinary Expenses for Private Schools from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. On behalf of Showa University, I would like to express my deepest thanks to all the authors and editors for their great contribution to the publication of this memorable book that accelerates research activity in lifestyle-related diseases. Akiyoshi Hosoyamada, M.D., Ph.D. President, Showa University Tokyo, Japan September 2007 v Preface The leading cause of death in Western countries and some developing countries is atherosclerotic cardiovascular diseases. Among them, acute myocardial infarction is the most common type of fatal disease, caused by the progression of atherosclerosis characterized by accumulation of choles terol in vascular walls. Development of atherosclerosis is greatly enhanced by major risk factors for cardiovascular diseases such as obesity, hyperlip idemia, diabetes (hyperglycemia), and hypertension. Among those, obesity frequently initiates a metabolic change that subsequently induces hyperlip idemia, diabetes, hypertension, and eventually atherosclerotic cardiovascu lar diseases. Because obesity and its related disorders largely depend on lifestyle factors such as high calorie intake and low physical activity, a series of disorders are termed lifestyle-related diseases.
Table of Contents
Forewords
Preface
Part 1 Regulation of Feeding and Energy Homeostasis in the Brain
Orphan Neuropeptides and the Regulation of Food Intake
Neuronal Mechanisms of Feeding Regulation by Peptides
Distribution and Localization of Galanin-Like Peptide (GALP) in Brain
Functional Analysis of GALP in Feeding Regulation
Regulation of Energy Homeostasis by GALP
Part 2 Lipid Metabolism and Atherosclerosis
Cholesterol Trafficking and Esterification with Relation to Atherosclerosis and Neurodegenerative Diseases
Atherogenic Lipoproteins in Type 2 Diabetes with Nephropathy
Regulatory Mechanisms for Cytosolic Prostaglandin E Synthase, cPGES/p23
Regulation of Intracellular Lipid Storage and Adipose Differentiation-Related Protein (ADRP)
Roles of Vasoactive Agents in Macrophage Foam Cell Formation and Atherosclerosis
Part 3 Risk Factors for Cardiovascular Diseases
Sleep Apnea and Metabolic and Cardiovascular Complications
Sleep Apnea Syndrome and Atherosclerosis
Significance of Small Dense Low-Density Lipoproteins in Coronary Heart Disease
Statin Decreases IL-1 and LPS-Induced Inflammatory Cytokines Production in Oral Epithelial Cells
Part 4 Poster Sessions
Onco-Suppressor p53 Protein Prevents an Alzheimer Disease Mouse Model, Pin1-Null Mouse from the Increase of Presenilin-1
Quantification of Mouse Oxidized Low-Density Lipoprotein by Sandwich ELISA
Regulation of sPLA2-IIA Expression in Cytokine-Stimulated Rat Fibroblasts
Comparison Between Small Dense LDL-Cholesterol and LDL-Cholesterol to Predict Coronary Events in Stable Coronary Heart Disease
Acceleration of Foam Cell Formation by Leptin in Human Monocyte-Derived Macrophages
by "Nielsen BookData"